A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2004
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248769 hydrolytic; inhibits arginyl endopeptidase or serine protease activity; air cleaner; fabric treatment
12/09/2004	US20040248292 Keratinocytes obtained from embryonic stem cells of mammals
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040247693 Modifying the fatty acid composition of cell membranes of organs and tissues
12/09/2004	US20040247686 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
12/09/2004	US20040247658 Delivery system with increased bioavailability
12/09/2004	US20040247650 Zinc, copper, selenium or iron bound to or absorbed into the material matrix; wound healing agents; neovascularization; antiulcer agents; burn treatments before skin transplants; acute infections
12/09/2004	US20040247631 Increasing the skin-moisturizing properties of polyols
12/09/2004	US20040247569 Reduction in bacterial colonization by administering bacteriophage compositions
12/09/2004	US20040247555 Methods of and compositions for modulating hair growth via P-cadherin modulators
12/09/2004	US20040247537 Uv-screening peptide-flavonoid conjugates
12/09/2004	CA2568609A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
12/09/2004	CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	CA2525692A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1484086A2 Composition for preventing and curing the acne comprising zinc gluconate and copper gluconate
12/08/2004	EP1484061A1 Drugs containing riboflavin-type compounds
12/08/2004	EP1484055A1 Delivery system with increased bioavailability
12/08/2004	EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing
12/08/2004	EP1483373A2 Surgical device for skin therapy or testing
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483260A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482967A1 Pharmaceutical and cosmetic compositions comprising plgf-1
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482959A1 Compositions and methods for treatment of skin disorders
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482942A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1482918A2 Utilization of ubiquinones for influencing the effect of histamine
12/08/2004	EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004	EP1482908A1 Soy composition for balancing combination skin
12/08/2004	EP1482907A2 Cosmetic composition that mimics sebum and the use thereof
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP0952836B1 Use of sulphoquinovosyldiacylglycerols for the treatment of inflammatory skin diseases
12/08/2004	EP0801570B1 Formulations and methods for reducing skin irritation
12/08/2004	CN1553816A Polysaccharide-containing compositions and use thereof
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1553795A Pharmaceutical and cosmetic compositions against skin aging
12/08/2004	CN1553794A Stable skin conditioning compositions containing retinoid boosters
12/08/2004	CN1553793A Hair follicle neogenesis by injection of follicle progenitor cells
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552432A Medicine for treating burn and scald, preparing method thereof
12/08/2004	CN1552430A Ointment for antipruritic and removing dandruff
12/08/2004	CN1552428A External antifungal Chinese medicine composition
12/08/2004	CN1552424A Chinese medicine for treating hair root imflammation of hair line
12/08/2004	CN1552423A Bedsore ointment and preparnig method thereof
12/08/2004	CN1552418A Plant lotion cream for eliminating freckles and its preparation
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552401A Compound barbiers liquid
12/08/2004	CN1552367A Menstruation regulating and face nourishing pills and their preparation
12/08/2004	CN1552329A Powder injection of cefpiramide
12/08/2004	CN1552302A Process for oxidative dyeing and composition for oxidative dyeing of keratinic fibres comprising a cationic amphiphilic polymer
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178895C Naprosyn precusor and its synthesis method and its application
12/08/2004	CN1178689C Process for preparing Chinese medicine as skin lotion
12/08/2004	CN1178686C Ointment for wound healing
12/08/2004	CN1178685C Medicine for treating burns and scalds
12/08/2004	CN1178681C Notoginseng and pangolin scales tinea curing pill
12/08/2004	CN1178680C Medicine of treating dermatosis for external use
12/08/2004	CN1178678C Process for preparing arnebia root medicine with broad-spectrum medical functions
12/08/2004	CN1178664C Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation
12/08/2004	CN1178656C Pharmaceutical composition
12/08/2004	CN1178654C Chloromycetin kibe ointment
12/08/2004	CN1178649C Copmound zinc undecylenate ointment for treating beriberi
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828451 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same

1 ... 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 ... 1065